超越10年视野:单纯人工腱索置换联合瓣环成形术的二尖瓣修复
该回顾性研究纳入2003至2010年在德国慕尼黑心脏中心连续接受单纯人工腱索置换联合瓣环成形术的346例退行性二尖瓣反流患者,中位随访10.86年。10年生存率为83.35%±2.15%,累积再手术率为7.84%±1.55%,累积显著复发二尖瓣反流率为13.31%±2.22%。作者结论认为该术式长期结果优异,并强调对重度退行性二尖瓣反流尤其左心室射血分数降低者早期干预的重要性。
要点
- 346例退行性二尖瓣反流患者接受单纯人工腱索置换联合瓣环成形术,中位随访10.86年。
- 10年生存率83.35%±2.15%,累积再手术率7.84%±1.55%。
- 年龄、糖尿病和左心室射血分数<55%为死亡的独立危险因素。
核心结论
- 在高度选择的患者队列中,单纯人工腱索置换联合瓣环成形术的二尖瓣修复展现了优异的长期结果和低再手术率。
- 作者强调对重度退行性二尖瓣反流尤其左心室射血分数降低患者早期干预的重要性。
研究设计与样本
- 回顾性研究,纳入2003至2010年在德国慕尼黑心脏中心连续接受单纯人工腱索置换联合瓣环成形术的退行性二尖瓣反流患者,共346例。
- 终点为生存率、二尖瓣再手术累积发生率和显著复发二尖瓣反流累积发生率。
- 中位随访10.86年(范围0.01-15.86年)。
主要发现
- 30天死亡率为0.58%(346例中2例),5年生存率为92.97%±1.41%。
- 5年累积复发二尖瓣反流发生率为6.87%±1.57%,累积再手术发生率为3.69%±1.05%。
- 10年生存率为83.35%±2.15%。
- 10年累积复发二尖瓣反流发生率为13.31%±2.22%,累积再手术发生率为7.84%±1.55%。
- Cox回归分析显示年龄、糖尿病和左心室射血分数<55%为死亡的独立危险因素;左心室射血分数<55%为显著复发二尖瓣反流的独立危险因素。
临床怎么用
- 作者认为该研究结果支持对重度退行性二尖瓣反流尤其左心室射血分数降低患者早期干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term outcomes of mitral valve repair by nonresection techniques, such as annuloplasty and chordal replacement, for degenerative mitral valve regurgitation were investigated. METHODS: All consecutive patients with degenerative mitral regurgitation who received solely chordal replacement and annuloplasty for mitral valve repair between 2003 and 2010 at the German Heart Center Munich were reviewed. The endpoints of this retrospective study were survival, cumulative incidence of reoperation on the mitral valve, and cumulative incidence of significant recurrent mitral regurgitation. RESULTS: A total of 346 patients were evaluated. The median follow-up period was 10.86 (range, 0.01-15.86) years. The 30-day mortality rate was 0.58% (n = 2 of 346), whereas the 5-year survival was 92.97% ± 1.41%. At 5 years, cumulative incidence of recurrent mitral regurgitation was 6.87% ± 1.57% and cumulative incidence of reoperation on the mitral valve was 3.69% ± 1.05%. Survival at 10 years was 83.35% ± 2.15%. At 10 years, cumulative incidence of recurrent mitral regurgitation was 13.31% ± 2.22% and cumulative incidence of reoperation was 7.84% ± 1.55%. Cox regression analysis identified age, diabetes mellitus, and reduced left ventricular ejection fraction <55% as independent risk factors for death. Left ventricular ejection fraction <55% was revealed as independent risk factor for significant recurrent mitral regurgitation. CONCLUSIONS: This study demonstrated excellent long-term outcomes with low incidence of reoperation after mitral valve repair using chordal replacement in a highly selected patient cohort. Our findings emphasized the importance of early intervention in severe degenerative mitral regurgitation, especially in patients with reduced left ventricular ejection fraction.
引用
- Lang M, Vitanova K, Voss B, et al. Beyond the 10-Year Horizon: Mitral Valve Repair Solely With Chordal Replacement and Annuloplasty. Ann Thorac Surg. 2022. PMID: 35690138. doi:10.1016/j.athoracsur.2022.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。